openPR Logo
Press release

Verrica Pharmaceuticals "VP-102" Market size expansion of Several Folds by 2032

03-06-2024 06:52 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Verrica Pharmaceuticals "VP-102" Market size expansion

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on VP-102 (Verrica Pharmaceuticals) providing insights into the drug market landscape and market forecast of VP-102 upto 2032. The report, titled "VP-102 Market Size, Forecast, and Emerging Insight - 2032" is now available for review and analysis.
Are you interested in finding out the projected market size of VP-102 in 2032? VP-102 Market Forecast
https://www.delveinsight.com/report-store/vp-102-emerging-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
The VP-102 Market Report offers projected sales forecasts for VP-102 for indications until 2032, categorized across the 7MM i.e. United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The report also provides extensive coverage and a competitive landscape analysis of competitors and marketed products indication. It also covers analyst views along with market drivers and barriers.
Verrica Pharmaceuticals VP-102 is serving as a beacon of hope for the patients suffering from the Molluscm Contagiosum.
What is a VP-102 Prescribed for?
The FDA granted approval to Verrica Pharmaceuticals for VP-102 (YCANTHE), marking it as the inaugural treatment specifically indicated for molluscm contagiosum, a viral skin disease.

The report extensively covers the details and developments related to VP-102, capturing important highlights on developmental pipeline, regulatory status and special designations of VP-102, route of administration, safety and efficacy details.

VP-102 Market Assessment
This report provides a detailed market assessment of VP-102 for Molluscm Contagiosum in the seven major markets, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. This segment of the report provides forecasted sales data from 2028 to 2032.

VP-102 Clinical Assessment
The report provides the clinical trials information of VP-102 for Molluscm Contagiosum covering trial interventions, trial conditions, trial status, start and completion dates. Report also includes important insights on regulatory milestones and other developmental activities related.
Do you know your drug's competitive positioning against VP-102? VP-102 Drugs Insights
https://www.delveinsight.com/report-store/vp-102-emerging-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

VP-102 Competitive Landscape
The report offers insights into the key players and companies actively engaged in the development of the specified indication. It provides valuable information regarding the competitive positioning of the VP-102.

VP-102 Market Size in the US
A dedicated section of the report focuses on the expected market size of VP-102 for the United States. DelveInsight's analysis includes market trends, growth projections, and key factors influencing the market dynamics, offering a comprehensive perspective for stakeholders.

Key Highlights of VP-102:

• The report contains forecasted sales of VP-102 for indication till 2032.
• Comprehensive coverage of the late-stage emerging therapies for Molluscm Contagiosum.
• The report also features the qualitative and quantitative analysis with analysts as well as KOL views for VP-102 in Molluscm Contagiosum.
Stay ahead in competition by leveraging insights on VP-102 market Report: Download VP-102 Market Report
https://www.delveinsight.com/sample-request/vp-102-emerging-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Why you should buy VP-102 Market Report:
• The report provides future market assessments for VP-102 for Molluscm Contagiosum in the 7 Major Markets, Advance qualitative analysis like SWOT, expert analysts' views, detailed overview of market competitors, and short analysis of other emerging therapies in Ulcerative Colitis.
• Leading VP-102 for Molluscm Contagiosum forecasted market data will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the VP-102
• Discover the competitive landscape of VP-102 through 7MM
• Get a Thorough Analysis of the VP-102 Development pipeline, Safety & Efficacy of the VP-102, and ROA
• Thorough VP-102 market forecast will help understand how drug is competing with other emerging VP-102
• Get analysis of the VP-102 clinical trial advancements and the detailed clinical assessment, regulatory and commercial assessment
• Drug Market forecasts are calculated after taking into consideration KOL viewpoints

Related Reports By DelveInsight:

Molluscm Contagiosum Pipeline https://www.delveinsight.com/report-store/molluscm-contagiosum-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's, "Molluscm Contagiosum Pipeline Insight, 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Molluscm Contagiosum pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. The key companies developing therapies include - Veloce Biopharma, Verrica Pharmaceuticals, Novan, Santalis Healthcare, and others.
It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Top Services Offered By DelveInsight:

Elevate healthcare strategies with Delveinsight Healthcare Consulting. Unlock insights, navigate challenges, and drive success in the dynamic healthcare landscape. https://www.delveinsight.com/consulting

Latest Reports Offered By DelveInsight:

Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products.

Symptomatic Partial-thickness Rotator Cuff Tears Market
https://www.delveinsight.com/report-store/symptomatic-partial-thickness-rotator-cuff-tears-market
DelveInsight's "Symptomatic Partial-thickness Rotator Cuff Tears Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Symptomatic Partial-thickness Rotator Cuff Tears, historical and forecasted epidemiology as well as the Symptomatic Partial-thickness Rotator Cuff Tears market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market
https://www.delveinsight.com/report-store/zika-virus-market
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Contact No.: +14699457679
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Verrica Pharmaceuticals "VP-102" Market size expansion of Several Folds by 2032 here

News-ID: 3415812 • Views:

More Releases from DelveInsight Business Research

Familial Chylomicronemia Syndrome Market to Expand Significantly by 2034, States DelveInsight Report
Familial Chylomicronemia Syndrome Market to Expand Significantly by 2034, States …
DelveInsight's "Familial Chylomicronemia Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Familial Chylomicronemia Syndrome, historical and forecasted epidemiology as well as the Familial Chylomicronemia Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Familial Chylomicronemia Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Familial Chylomicronemia Syndrome
Generalized Anxiety Disorder Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight
Generalized Anxiety Disorder Pipeline 2025: Therapies, MOA Insights, and Key Cli …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Generalized Anxiety Disorder pipeline constitutes 12+ key companies continuously working towards developing 15+ Generalized Anxiety Disorder treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Generalized Anxiety Disorder Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Generalized Anxiety
Primary Mitochondrial Myopathies Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight
Primary Mitochondrial Myopathies Pipeline 2025: MOA, ROA, FDA-Approved Drugs, an …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Primary Mitochondrial Myopathies pipeline constitutes 4+ key companies continuously working towards developing 4+ Primary Mitochondrial Myopathies treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Primary Mitochondrial Myopathies Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Primary Mitochondrial
Chlamydia Infections Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight
Chlamydia Infections Pipeline 2025: Therapies Under Investigation, Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chlamydia Infections pipeline constitutes 5+ key companies continuously working towards developing 5+ Chlamydia Infections treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Chlamydia Infections Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also

All 5 Releases


More Releases for Insight

Europe Predictive Maintenance Market, Segmentation, Insight, Scope, & Insight by …
Europe Predictive Maintenance Market will project a CAGR of 40.10% during the forecast up to 2029.  Predictive maintenance is known to lead a huge increase in ROI. It can decline maintenance costs up to 25%-30%, decrease breakdowns to 70%-75%, and reduce downtime to 35%-45%. These services are being highly deployed as they save overall cost for enterprises.  Europe Predictive Maintenance Market was valued at USD 490.88 million in 2021 and is expected
Returnable Transport Packaging Market, Segmentation, Insight, Scope, & Insight b …
Returnable Transport Packaging Market grows at a CAGR of 5.9% in the forecast period 2021-2028. Market Analysis & Insights: Returnable Transport Packaging Market  Returnable transport packaging market will grow at a rate of 5.9% for the forecast period of 2021 to 2028. Rising reduction in cost of supply chain cycle and reduction of operational cost which acts as an essential factor driving the returnable transport packaging market.  Traditional methods of packaging that
Next-Generation Firewall Market, Segmentation, Insight, Scope, & Insight by 2028 …
Next-Generation Firewall Market grows at a CAGR of 11.9% in the forecast period 2021-2028. Market Analysis & Insights: Next-Generation Firewall Market  The next-generation firewall market is expected to witness market growth at a rate of 11.9% in the forecast period of 2021 to 2028. Data Bridge Market Research report on next-generation firewall market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing
System Integration Market, Segmentation, Insight, Scope, & Insight by 2028.
System Integration Market grows at a CAGR of 10.67% in the forecast period 2022-2029. System Integration Market Share Analysis  Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to
Crypto Asset Management Market, Segmentation, Insight, Scope, & Insight by 2029.
Crypto Asset Management Market grows at a CAGR of 25.50% in the forecast period 2022-2029. Market Analysis & Size: Crypto Asset Management Market  Cryptocurrency is one of the more exciting investing prospects to emerge in recent years. An increasing number of institutional investors and wealth managers who have never invested in cryptocurrencies are getting ready to do so in the upcoming year as their prices continue to rise. The global market
Optical Waveguide Display Market, Segmentation, Insight, Scope, & Insight by 202 …
Optical Waveguide Display Market grows at a CAGR of 12.90% in the forecast period 2022-2029. Market Analysis & Insights: Optical Waveguide Display Market  Augmented reality (AR) portable and wearable devices have emerged as one of the greatest technology in past few years. Optical waveguide technology has the best potential to enable the consumer-grade AR glasses owing to its appearance, mass production capability and optical performance. It is being considered an unparalleled choice